Litcius/Paper detail

Antibody drug conjugates: The dos and don'ts in clinical development

Anthony W. Tolcher

2022Pharmacology & Therapeutics19 citationsDOI

Topics & Concepts

Clinical trialDrug developmentDrugMedicinePharmacologyAntibody-drug conjugateAntibodyInternal medicineImmunologyMonoclonal antibodyHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCancer Treatment and Pharmacology
Antibody drug conjugates: The dos and don'ts in clinical development | Litcius